BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 32763480)

  • 1. Reducing Read Time of Point-of-Care Test Does Not Affect Detection of Hepatitis C Virus and Reduces Need for Reflex RNA.
    Smookler D; Vanderhoff A; Biondi MJ; Valencia J; Ryan P; Karkada J; Hong R; Sattar I; Mandel E; Gjevori M; Casey J; Fletcher D; Shah H; Hansen BE; Capraru C; Janssen HLA; Lazarus JV; Feld JJ
    Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1451-1458.e4. PubMed ID: 32763480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of the OraQuick Hepatitis C virus antibody test in oral fluid and fingerstick blood before and after treatment-induced viral clearance.
    Pallarés C; Carvalho-Gomes Â; Hontangas V; Conde I; Di Maira T; Aguilera V; Benlloch S; Berenguer M; López-Labrador FX
    J Clin Virol; 2018 May; 102():77-83. PubMed ID: 29525634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of a one-step screening and diagnosis strategy for viremic HCV infection among people who inject drugs in Catalonia.
    Saludes V; Antuori A; Folch C; González N; Ibáñez N; Majó X; Colom J; Matas L; Casabona J; Martró E;
    Int J Drug Policy; 2019 Dec; 74():236-245. PubMed ID: 31706159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of two rapid screening assays for detecting hepatitis C antibodies in resource-constrained settings.
    Kosack CS; Nick S
    Trop Med Int Health; 2016 May; 21(5):603-9. PubMed ID: 26945920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of hepatitis C virus point-of-care RNA viral load testing compared with laboratory-based testing on uptake of RNA testing and treatment, and turnaround times: a systematic review and meta-analysis.
    Trickey A; Fajardo E; Alemu D; Artenie AA; Easterbrook P
    Lancet Gastroenterol Hepatol; 2023 Mar; 8(3):253-270. PubMed ID: 36706775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Guideline for interpretation and report of the antibody to hepatitis C virus. Grupo de Desarrollo de la Guía ].
    Contreras AM; Ochoa-Jiménez RJ; Kershenobich D; Granados-García V; Conde-González CJ; Celis A; Pérez-Gómez HR; Ruelas-Hernández S; Romero-Flores P; Alcántar-Luna E; Sierra-García de Quevedo J; Ancona-Pisté O;
    Rev Invest Clin; 2012; 64(6 Pt 2):641-78. PubMed ID: 23593783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of Anti-HCV S/CO Value in Detecting Viremia in Patients with Hepatitis C Virus Infection].
    Aydın G; Adaleti R; Boz ES; Yücel FM; Özhan HK; Aksaray S
    Mikrobiyol Bul; 2020 Jan; 54(1):110-119. PubMed ID: 32050882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.
    Bregenzer A; Conen A; Knuchel J; Friedl A; Eigenmann F; Näf M; Ackle P; Roth M; Fux CA
    Swiss Med Wkly; 2017; 147():w14544. PubMed ID: 29185250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.
    Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M
    J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C care cascade among patients with and without tuberculosis: Nationwide observational cohort study in the country of Georgia, 2015-2020.
    Baliashvili D; Blumberg HM; Gandhi NR; Averhoff F; Benkeser D; Shadaker S; Gvinjilia L; Turdziladze A; Tukvadze N; Chincharauli M; Butsashvili M; Sharvadze L; Tsertsvadze T; Zarkua J; Kempker RR
    PLoS Med; 2023 May; 20(5):e1004121. PubMed ID: 37141386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study.
    Grebely J; Lamoury FMJ; Hajarizadeh B; Mowat Y; Marshall AD; Bajis S; Marks P; Amin J; Smith J; Edwards M; Gorton C; Ezard N; Persing D; Kleman M; Cunningham P; Catlett B; Dore GJ; Applegate TL;
    Lancet Gastroenterol Hepatol; 2017 Jul; 2(7):514-520. PubMed ID: 28442271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of biochemical, hematological, RIBA and PCR assays in predicting viremia in anti-HCV positive patients.
    Sirin MC; Cicioglu Aridogan B; Sesli Cetin E; Sirin FB
    J Infect Dev Ctries; 2019 Aug; 13(8):736-743. PubMed ID: 32069258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C Virus Screening of High-Risk Patients in a Canadian Emergency Department.
    Ragan K; Pandya A; Holotnak T; Koger K; Collins N; Swain MG
    Can J Gastroenterol Hepatol; 2020; 2020():5258289. PubMed ID: 32211349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a new point-of-care oral anti-HCV test for screening of hepatitis C virus infection.
    Liu L; Zhang M; Hang L; Kong F; Yan H; Zhang Y; Feng X; Gao Y; Wang C; Ma H; Liu X; Zhan M; Pan Y; Xu H; Niu J
    Virol J; 2020 Jan; 17(1):14. PubMed ID: 32005264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus infection in hemodialysis patients: comparison of two new hepatitis C antibody assays with a second-generation assay.
    al Meshari K; Alfurayh O; Al Ahdal M; Qunibi W; Kessie G; De Vol E
    J Am Soc Nephrol; 1995 Nov; 6(5):1439-44. PubMed ID: 8589320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid point-of-care HCV RNA quantification in capillary whole blood for diagnosing chronic HCV infection, monitoring treatment and detecting reinfection.
    Bregenzer A; Warmann N; Ottiger C; Fux CA
    Swiss Med Wkly; 2019 Oct; 149():w20137. PubMed ID: 31656039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative assessment of HCV load in chronic hemodialysis patients: a cross-sectional survey.
    Fabrizi F; Martin P; Dixit V; Brezina M; Cole MJ; Gerosa S; Vinson S; Mousa M; Gitnick G
    Nephron; 1998 Dec; 80(4):428-33. PubMed ID: 9832642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of hepatitis C virus RNA detection using capillary blood by finger prick (GenXpert system)-Hepatitis C fingerprick study.
    Bielen R; Koc ÖM; Busschots D; Verrando R; Nevens F; Robaeys G
    J Viral Hepat; 2020 Jul; 27(7):709-714. PubMed ID: 32106345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Xpert HCV VL Fingerstick point-of-care assay and dried blood spot HCV-RNA testing as simplified diagnostic strategies among people who inject drugs in Catalonia, Spain.
    Saludes V; Antuori A; Lazarus JV; Folch C; González-Gómez S; González N; Ibáñez N; Colom J; Matas L; Casabona J; Martró E
    Int J Drug Policy; 2020 Jun; 80():102734. PubMed ID: 32470849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of active hepatitis C in a single visit and linkage to care among marginalized people using a mobile unit in Madrid, Spain.
    Ryan P; Valencia J; Cuevas G; Torres-Macho J; Troya J; Pueyo Á; José Muñoz-Gómez M; Muñoz-Rivas N; Vázquez-Morón S; Martinez I; Lazarus JV; Resino S
    Int J Drug Policy; 2021 Oct; 96():103424. PubMed ID: 34429222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.